NextCure NXTC
NASDAQ NXTC
$5.41 -0.03 (-0.46%)
At close: Oct 21, 2026 · 4:00 PM EDT

NextCure (NXTC) Preferred Stock Liabilities (2018 - 2025)

Updated

NextCure (NXTC) reported Preferred Stock Liabilities of $2 million for Q2 2025.

Analysis

NextCure (NXTC) Preferred Stock Liabilities (2018 - 2025) Analysis & Trends

At the end of FY2018, NextCure posted Preferred Stock Liabilities of $162.22 million.

  • The Q2 2025 figure ranks as the highest quarterly Preferred Stock Liabilities since Q1 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 NextCure 29.52 Mn -91.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.00 Mn
Mar 31, 2019 162.22 Mn
Dec 31, 2018 162.22 Mn
Sep 30, 2018 71.00 Mn
Jun 30, 2018 71.00 Mn
Mar 31, 2018 40.00 Mn
API Access

NextCure Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NXTC&period=max&api_key=YOUR_API_KEY